SCHEMBL6779695

SCHEMBL6779695

COc1ccc(N(Cc2ccccc2-c2ccccc2)C(=O)c2ccccc2Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ LTB4R2 Q9NPC1 1/20 0.49
▸ TP53 P04637 2/20 0.47
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ LPAR1 Q92633 1/20 0.43
▸ TSHR P16473 1/20 0.42
▸ HPGD P15428 1/20 0.41
▸ PTGES O14684 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ PDK1 Q15118 2/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ RNF4 P78317 1/20 0.41
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778364 0.85 PTGES (0.56) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6784549 0.85 LTB4R2 (0.48) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6778305 0.84 LTB4R2 (0.52) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6781046 0.83 MEN1 (0.49) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6780398 0.83 LMNA (0.51) LMNAALDH1A1LTB4R2TP53LPAR1
SCHEMBL6785514 0.83 LTB4R2 (0.46) ALDH1A1LTB4R2MEN1KMT2AHPGD
SCHEMBL6780300 0.82 LTB4R2 (0.46) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6774057 0.81 LMNA (0.46) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL6774063 0.80 LTB4R2 (0.50) LMNAALDH1A1LTB4R2TP53MEN1
SCHEMBL16234743 0.78 KMT2A (0.53) ALDH1A1LTB4R2TP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT LMNA 4203/4885ALDH1A1 646/4885LTB4R2 1613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback